PURPLE INNOVATION, INC. (NASDAQ:PRPL – Free Report) – Research analysts at Roth Capital decreased their Q3 2025 earnings per share (EPS) estimates for PURPLE INNOVATION in a research report issued on Wednesday, July 30th. Roth Capital analyst M. Koranda now anticipates that the company will earn ($0.09) per share for the quarter, down from their prior forecast of ($0.07). The consensus estimate for PURPLE INNOVATION’s current full-year earnings is ($0.47) per share. Roth Capital also issued estimates for PURPLE INNOVATION’s Q4 2025 earnings at ($0.02) EPS, FY2025 earnings at ($0.32) EPS, Q2 2026 earnings at ($0.06) EPS, Q4 2026 earnings at ($0.02) EPS and FY2026 earnings at ($0.23) EPS.
Separately, Wall Street Zen downgraded PURPLE INNOVATION from a “hold” rating to a “sell” rating in a research report on Friday, July 18th.
PURPLE INNOVATION Trading Down 0.3%
Shares of NASDAQ:PRPL opened at $0.81 on Friday. The company has a market capitalization of $87.14 million, a P/E ratio of -1.04 and a beta of 1.42. PURPLE INNOVATION has a 1 year low of $0.56 and a 1 year high of $1.37. The company has a debt-to-equity ratio of 54.69, a current ratio of 1.49 and a quick ratio of 0.64. The business’s 50 day simple moving average is $0.77 and its 200 day simple moving average is $0.82.
PURPLE INNOVATION (NASDAQ:PRPL – Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.01. The business had revenue of $105.10 million for the quarter, compared to the consensus estimate of $103.69 million. PURPLE INNOVATION had a negative return on equity of 472.12% and a negative net margin of 18.43%.
Institutional Investors Weigh In On PURPLE INNOVATION
A number of large investors have recently modified their holdings of the business. Invenomic Capital Management LP acquired a new stake in shares of PURPLE INNOVATION in the 4th quarter valued at $620,000. JPMorgan Chase & Co. boosted its holdings in shares of PURPLE INNOVATION by 2,140.2% in the 4th quarter. JPMorgan Chase & Co. now owns 608,144 shares of the company’s stock valued at $474,000 after purchasing an additional 580,997 shares in the last quarter. Crumly & Associates Inc. boosted its holdings in shares of PURPLE INNOVATION by 55.6% in the 2nd quarter. Crumly & Associates Inc. now owns 254,613 shares of the company’s stock valued at $186,000 after purchasing an additional 90,950 shares in the last quarter. Nuveen LLC acquired a new stake in shares of PURPLE INNOVATION in the 1st quarter valued at $173,000. Finally, Squarepoint Ops LLC boosted its holdings in shares of PURPLE INNOVATION by 219.7% in the 4th quarter. Squarepoint Ops LLC now owns 178,052 shares of the company’s stock valued at $139,000 after purchasing an additional 122,358 shares in the last quarter. Institutional investors and hedge funds own 88.41% of the company’s stock.
About PURPLE INNOVATION
Purple Innovation, Inc designs and manufactures sleep and other products in the United States and internationally. The company offers mattresses, pillows, cushions, bases, sheets, platforms, adjustable bases, mattress protectors, foundations, blankets, duvets, duvet covers, seat cushions, and pet beds under the Purple brand.
Featured Stories
- Five stocks we like better than PURPLE INNOVATION
- Health Care Stocks Explained: Why You Might Want to Invest
- Will Hims & Hers Fall Along With Novo Nordisk?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
- Canada Bond Market Holiday: How to Invest and Trade
- Rocket Lab Reports Next Week: Here’s What Investors Should Know
Receive News & Ratings for PURPLE INNOVATION Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURPLE INNOVATION and related companies with MarketBeat.com's FREE daily email newsletter.